Kashiv BioSciences
New Jersey, United States · Biotechnology, Health Care, Manufacturing
Kashiv BioSciences, LLC is a company that focuses on developing and manufacturing high-quality, affordable biosimilars to improve patients’ lives worldwide.
Key facts
- Headquarters
- New Jersey, United States
- Employees
- 487
- Industries
- Biotechnology, Health Care, Manufacturing
- Website
- www.kashivbiosciences.com
- Company page
Recent activity at Kashiv BioSciences
- : Kashiv BioSciences Appoints Viet Nguyen as Chief Operating Officer
- : Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat.
- : Dr. Sandeep Nilkanth Athalye Appointed as Global Chief Executive Officer at Kashiv BioSciences, LLC
- : Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab) (date Fundz recorded it)
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Kashiv BioSciences funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Debt Financing | $72.2M |
Leadership
- Kishore Kumar, Senior General Manager
- Shailesh Limbachiya, Human Resources Business Partner
- Viet Nguyen, Chief Operating Officer
- Paras Vasanani, SVP & Cbo-bd&l, Portfolio, Corporate Strategy, Alliance & Project Management
- Chandramauli Rawal, Chief Operating Officer
- Sandeep Nilkanth Athalye, Chief Executive Officer
Verified email and direct lines for Kashiv BioSciences’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Kashiv BioSciences files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Kashiv BioSciences in the news
- Kashiv BioSciences and CRISTÁLIA Enter into Licensing and Supply Agreement for Omalizumab Biosimilar (ADL-018) in Latin America - BioSpace (Sep 12, 2025)
- Kashiv BioSciences and JAMP Pharma Corporation Announce the Launch of PEXEGRA - Business Wire (Sep 24, 2025)
- Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader - GlobeNewswire (Aug 10, 2026)
- Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab) - BioSpace (Oct 07, 2025)
- Kashiv BioSciences Secures $150 Million Debt Financing from GoldenTree Asset Management - Business Wire (Apr 07, 2025)
- Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada - BioSpace (Feb 26, 2025)
- Kashiv BioSciences Strengthens Executive Leadership with New Chief Operating Officer and Senior Vice President of Regulatory Affairs - Business Wire (Apr 14, 2026)
- Kashiv BioSciences Announces Validation and Acceptance of Market Authorization Application by Health Canada for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab) - Business Wire (Jun 02, 2026)
Companies similar to Kashiv BioSciences
- Helvoet Polymer Technologies B.V · Biotechnology, Health Care, Manufacturing
- Cupid Ltd · Biotechnology, Health Care, Manufacturing
- Zylox-Tonbridge · Biotechnology, Health Care, Manufacturing
- Dipharma · Biotechnology, Health Care, Manufacturing
- Boditech Med · Biotechnology, Health Care, Manufacturing
About Kashiv BioSciences: questions and answers
What does Kashiv BioSciences do?
Kashiv BioSciences, LLC is a company that focuses on developing and manufacturing high-quality, affordable biosimilars to improve patients’ lives worldwide.
Where is Kashiv BioSciences headquartered?
Kashiv BioSciences is headquartered in New Jersey, United States.
How many employees does Kashiv BioSciences have?
Kashiv BioSciences has about 487 employees.
Has Kashiv BioSciences raised funding?
Yes. Fundz has recorded 1 funding event for Kashiv BioSciences. The most recent, Debt Financing of $72.2M, was in Dec 2025.
Who leads Kashiv BioSciences?
Sandeep Nilkanth Athalye is a Chief Executive Officer at Kashiv BioSciences.
What is the latest news on Kashiv BioSciences?
On Apr 14, 2026, Kashiv BioSciences Appoints Viet Nguyen as Chief Operating Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy